Sahlgrenska Center for Cancer Research
Translational cancer research with the patient in focus
Here at Sahlgrenska Center for Cancer Research we focus our research with the patient in mind. This is so that the cancer patient could receive a better care in the future than in today’s society. Through a close collaboration with the Sahlgrenska University Hospital, we at the centre are trying to find new methods and treatments, which later can be tested and applied directly within the cancer care.
Our research groups work widely
Today our 25 research groups work in a wide spectrum of cancer related research questions, but they all have translational cancer research as a common denominator. Example of areas which are studied are brain cancers, lung cancer, breast cancer, melanoma, radiotherapy, prostate cancer and leukaemia. Other research areas at the centre are also epigenetics, ovarian and cervical cancer, sarcoma, neuroendocrine and thyroid cancers, pancreatic cancer and salivary gland tumors.
The research is in some cases used for developing diagnostic and prognostic tools, which in the longer term can improve the cancer care and ensure that the right treatments are being used.
Overbridging post graduate studies
Through the Cancer Research South (CARES) School we at Sahlgrenska Center for Cancer Research also provide courses within cancer research. As for our work, these courses are overbridging research and clinical work as well. CARES is a graduate research school which offers courses to PhD Students at University of Gothenburg and Lund University, which have both been part of the previous strategic program BioCARE.
Latest news
-
Health and medicinePekka Jaako received funding from The Swedish Childhood CancerFund
-
Health and medicineProstate cancer medicine not a cure forCOVID-19
-
Health and medicineA total of SEK 31,2 million from the Swedish CancerSociety
-
Health and medicineMultiple tumors without kinship occur simultaneously in the smallintestine
-
Health and medicineSRC starting grant for research on lung cancer cell migration to new sites
Latest SCCR publications
- Validated biomarker assays confirm that ARID1A loss is confounded with MMR defi… (External link)
- Pan-cancer analysis identifies BIRC5 as a prognostic biomarker (External link)
- eIF6 rebinding dynamically couples ribosome maturation and translation (External link)
- The outcome of targeted NGS screening in patients with syndromic forms of sagit… (External link)
- The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclea… (External link)
- Antigen-Presenting B Cells Program the Efferent Lymph T Helper Cell Response (External link)
- Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitr… (External link)
- SCC publications (before name change) (External link)
